Physician profile
Ramon E Rivera
NPI 1841299005
$3,222.13
in general payments reported to CMS, 2019-2025
12 companies · $69.13 in 2025
The $69.13 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $507 · 2020: $17.58 · 2021: $14.64 · 2022: $2,027 · 2023: $353 · 2024: $234 · 2025: $69.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $656.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,165.13 | 2022-2023 | Da Vinci Surgical System |
| Covidien Lp | $444.17 | 2019-2020 | |
| Davol INC. | $195.17 | 2024-2025 | Phasix Mesh |
| Ethicon US, LLC | $183.63 | 2023-2024 | Echelon Endopath, Vistaseal, Echelon Flex |
| Medtronic, INC. | $77.18 | 2023 | Signia, Ligasure |
| Novo Nordisk INC | $42.32 | 2019-2023 | Wegovy |
| Kerecis Limited | $27.02 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Vivus LLC | $25.00 | 2019 | |
| Endo Pharmaceuticals INC. | $20.59 | 2019 | |
| Currax Pharmaceuticals LLC | $14.64 | 2021 | |
| Nalpropion Pharmaceuticals LLC | $13.68 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $13.60 | 2023 | Caldolor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramon Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.